These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29746868)
1. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation. Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway. Pan Q; Liu R; Banu H; Ma L; Li H Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763 [TBL] [Abstract][Full Text] [Related]
3. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation. Zhu Y; Hu Q; Li H Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403 [TBL] [Abstract][Full Text] [Related]
4. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo. Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579 [TBL] [Abstract][Full Text] [Related]
5. ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways. Xu J; Zhu Y; Wang F; Zhou Y; Xia G; Xu W Biochem Biophys Res Commun; 2019 Oct; 518(3):584-589. PubMed ID: 31451223 [TBL] [Abstract][Full Text] [Related]
6. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer. Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504 [TBL] [Abstract][Full Text] [Related]
8. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents. Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011 [TBL] [Abstract][Full Text] [Related]
9. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746 [TBL] [Abstract][Full Text] [Related]
10. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration. Cushman I; Casey PJ J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth. Wang M; Hossain MS; Tan W; Coolman B; Zhou J; Liu S; Casey PJ Oncogene; 2010 Sep; 29(35):4959-70. PubMed ID: 20622895 [TBL] [Abstract][Full Text] [Related]
12. Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms. Lau HY; Tang J; Casey PJ; Wang M Oncogene; 2017 Jul; 36(27):3934-3942. PubMed ID: 28192404 [TBL] [Abstract][Full Text] [Related]
13. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia. Marín-Ramos NI; Balabasquer M; Ortega-Nogales FJ; Torrecillas IR; Gil-Ordóñez A; Marcos-Ramiro B; Aguilar-Garrido P; Cushman I; Romero A; Medrano FJ; Gajate C; Mollinedo F; Philips MR; Campillo M; Gallardo M; Martín-Fontecha M; López-Rodríguez ML; Ortega-Gutiérrez S J Med Chem; 2019 Jul; 62(13):6035-6046. PubMed ID: 31181882 [TBL] [Abstract][Full Text] [Related]
14. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal. Chai TF; Manu KA; Casey PJ; Wang M Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852 [TBL] [Abstract][Full Text] [Related]
15. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism. Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia. Sun WT; Xiang W; Ng BL; Asari K; Bunte RM; Casey PJ; Wang M; Chuah C Exp Hematol; 2016 Mar; 44(3):189-93.e2. PubMed ID: 26706195 [TBL] [Abstract][Full Text] [Related]
17. Isoprenylcysteine carboxyl methyltransferase inhibitors exerts anti-inflammatory activity. Yang WS; Kim HG; Lee Y; Yoon K; Kim S; Kim JH; Cho JY Biochem Pharmacol; 2020 Dec; 182():114219. PubMed ID: 32931773 [TBL] [Abstract][Full Text] [Related]
18. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt). Ramanujulu PM; Yang T; Yap SQ; Wong FC; Casey PJ; Wang M; Go ML Eur J Med Chem; 2013 May; 63():378-86. PubMed ID: 23514631 [TBL] [Abstract][Full Text] [Related]